Literature DB >> 15809464

Pharmacologic and surgical management of obesity in primary care: a clinical practice guideline from the American College of Physicians.

Vincenza Snow1, Patricia Barry, Nick Fitterman, Amir Qaseem, Kevin Weiss.   

Abstract

This guideline is based on the evidence report and accompanying background papers developed by the Southern California Evidence-Based Practice Center. The American College of Physicians nominated this topic to the Agency for Healthcare Research and Quality Evidence-Based Practice Center program as part of a concerted effort to complement the guidelines of the U.S. Preventive Services Task Force. The College recommends that all clinicians refer to the Task Force recommendations as part of an overall strategy for managing overweight and obesity, which should always include appropriate diet and exercise for all patients who are overweight or obese. The intent of this guideline is to provide recommendations based on a review of the evidence on pharmacologic and surgical treatments of obesity. The target audience is all clinicians caring for obese patients, defined as a body mass index of 30 kg/m2 or greater. This guideline is not intended to be used by commercial weight loss centers or for direct-to-consumer marketing by manufacturers and does not apply to patients with body mass indices below 30 kg/m2.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15809464     DOI: 10.7326/0003-4819-142-7-200504050-00011

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  66 in total

1.  Perspectives on comparative effectiveness research: views from diverse constituencies.

Authors:  Dave Nellesen; Howard G Birnbaum; Paul E Greenberg
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 2.  Coverage of obesity treatment: a state-by-state analysis of Medicaid and state insurance laws.

Authors:  Jennifer S Lee; Jennifer L O Sheer; Nancy Lopez; Sara Rosenbaum
Journal:  Public Health Rep       Date:  2010 Jul-Aug       Impact factor: 2.792

3.  Does pharmacologic weight reduction improve blood pressure?

Authors:  Helmy M Siragy
Journal:  Curr Hypertens Rep       Date:  2006-08       Impact factor: 5.369

4.  Drug treatment for obesity in the post-sibutramine era.

Authors:  Bernard M Y Cheung
Journal:  Drug Saf       Date:  2011-08-01       Impact factor: 5.606

Review 5.  Interventions to reduce weight gain in schizophrenia.

Authors:  G Faulkner; T Cohn; G Remington
Journal:  Cochrane Database Syst Rev       Date:  2007-01-24

Review 6.  Managing obesity in adults in primary care.

Authors:  Gilles Plourde; Denis Prud'homme
Journal:  CMAJ       Date:  2012-05-14       Impact factor: 8.262

7.  Bands and bypasses: 30-day morbidity and mortality of bariatric surgical procedures as assessed by prospective, multi-center, risk-adjusted ACS-NSQIP data.

Authors:  Robert T Lancaster; Matthew M Hutter
Journal:  Surg Endosc       Date:  2008-09-20       Impact factor: 4.584

8.  Changes in body weight and blood pressure: paradoxical outcome events in overweight and obese subjects with cardiovascular disease.

Authors:  R V Seimon; D Espinoza; L Ivers; V Gebski; N Finer; U F Legler; A M Sharma; W P T James; W Coutinho; I D Caterson
Journal:  Int J Obes (Lond)       Date:  2014-01-10       Impact factor: 5.095

9.  Pharmacotherapy for obesity.

Authors:  Mingfang Li; Bernard M Y Cheung
Journal:  Br J Clin Pharmacol       Date:  2009-12       Impact factor: 4.335

10.  Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s.

Authors:  Catherine E Thomas; Elizabeth A Mauer; Alpana P Shukla; Samrat Rathi; Louis J Aronne
Journal:  Obesity (Silver Spring)       Date:  2016-09       Impact factor: 5.002

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.